Balchem (BCPC) | Stock Overview & Key Data
Balchem Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $186.03 on July 29, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Balchem BCPC | 5.36B Mid-cap | -0.41% | -3.30% | 1.81% | 5.39% | 2.49% | -1.89% | 25.81% | 63.41% |
| Linde plc LIN | 216.02B Mega-cap | -1.24% | -0.19% | 5.67% | 13.79% | 13.79% | 6.64% | 69.67% | 93.71% |
| Sherwin-Williams SHW | 86.63B Large-cap | -0.28% | -1.79% | 4.55% | 6.48% | 5.52% | 8.68% | 40.90% | 70.14% |
| Eastman Chemical EMN | 8.66B Mid-cap | 0.45% | 0.41% | -1.47% | -7.98% | -9.31% | -18.46% | -9.29% | 5.98% |
| Westlake WLK | 9.74B Mid-cap | 4.45% | 12.56% | -8.79% | -22.31% | -23.76% | -43.35% | -9.74% | 49.03% |
| Albemarle ALB | 7.91B Mid-cap | 5.43% | 17.89% | 1.07% | -23.44% | -21.14% | -31.66% | -67.36% | -14.81% |
Ownership & Short Interest
Balchem Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Balchem would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is BCPC's 52-week high and low?
In the last 52 weeks, Balchem reached a high of $186.03 (on July 29, 2024) and a low of $145.70 (on April 9, 2025).
What is the market cap and P/E ratio for BCPC?
Curious about Balchem's size and valuation? Its market capitalization stands at 5.36B. When it comes to valuation, the P/E ratio (trailing twelve months) is 39.28, and the forward P/E (looking ahead) is 33.65.
Does BCPC pay dividends? If so, what's the yield?
Yes, Balchem is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.54%, and the company has paid an average of $0.79 per share annually over the past 3 years.
Who are Balchem's main competitors or similar companies to consider before investing?
When looking at Balchem, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
| Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
|---|---|---|---|---|---|
| Linde plc LIN | 216.02B | Basic Materials | Specialty Chemicals | 6.64% | 69.67% |
| Sherwin-Williams SHW | 86.63B | Basic Materials | Specialty Chemicals | 8.68% | 40.90% |
| Eastman Chemical EMN | 8.66B | Basic Materials | Specialty Chemicals | -18.46% | -9.29% |
| Westlake WLK | 9.74B | Basic Materials | Specialty Chemicals | -43.35% | -9.74% |
| Albemarle ALB | 7.91B | Basic Materials | Specialty Chemicals | -31.66% | -67.36% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Balchem Corporation? (e.g., ROE, Debt/Equity)
To get a sense of Balchem's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.94%, the Debt to Equity ratio from the most recent quarter is 17.21, and its Gross Profit Margin stands at 35.19%.
What is the recent revenue and earnings growth for BCPC?
Looking at Balchem's growth, its revenue over the trailing twelve months (TTM) was $965M. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.50%, and quarterly earnings saw a YoY growth of 27.80%.
How much of BCPC stock is held by insiders and institutions?
Wondering who owns Balchem stock? Company insiders (like executives and directors) hold about 0.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 90.36%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.